Larimar Therapeutics, Inc.(LRMR)

Biotechnology · Bala Cynwyd, PA

$2.87+0.01 (+0.17%)

Delayed quote: Oct 6, 2026, 11:50 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T15:52:03.587Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:52:03.587Z.

Quote observation: 2026-10-06T15:50:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.865
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.99

FMP input reference: 820e6844a86ebcce87b4cbc727545bf8fd5f2e7882f78b89935f6b0fc3bd738c

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

LRMR PE Ratio Metrics

PE RATIO

N/A

LRMR Competitors' PE Ratio

LRMR

Larimar Therapeutics, Inc.

Current

Market Cap

$297.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BNTC

Benitec Biopharma Inc.

vs LRMR

Market Cap

$303.05M

PE Ratio

N/A

TTM Avg

396.83

3Y Avg

396.83

5Y Avg

396.83

BBOT

BridgeBio Oncology Therapeutics Inc.

vs LRMR

Market Cap

$290.91M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LAB

Standard BioTools Inc.

vs LRMR

Market Cap

$290.74M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABEO

Abeona Therapeutics Inc.

vs LRMR

Market Cap

$288.87M

PE Ratio

N/A

TTM Avg

6.29

3Y Avg

6.29

5Y Avg

6.29

MOBI

Mobia Medical, Inc. Common Stock

vs LRMR

Market Cap

$308.55M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FULC

Fulcrum Therapeutics, Inc.

vs LRMR

Market Cap

$283.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INDP

Indaptus Therapeutics, Inc.

vs LRMR

Market Cap

$283.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACB

Aurora Cannabis Inc.

vs LRMR

Market Cap

$280.60M

PE Ratio

N/A

TTM Avg

46.08

3Y Avg

46.08

5Y Avg

46.08

FATE

Fate Therapeutics, Inc.

vs LRMR

Market Cap

$279.16M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Larimar Therapeutics, Inc. (LRMR)	$297.62M	N/A	N/A	N/A	N/A
Benitec Biopharma Inc. (BNTC)vs ›	$303.05M	N/A	396.83	396.83	396.83
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$290.91M	N/A	N/A	N/A	N/A
Standard BioTools Inc. (LAB)vs ›	$290.74M	N/A	N/A	N/A	N/A
Abeona Therapeutics Inc. (ABEO)vs ›	$288.87M	N/A	6.29	6.29	6.29
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$308.55M	N/A	N/A	N/A	N/A
Fulcrum Therapeutics, Inc. (FULC)vs ›	$283.92M	N/A	N/A	N/A	N/A
Indaptus Therapeutics, Inc. (INDP)vs ›	$283.42M	N/A	N/A	N/A	N/A
Aurora Cannabis Inc. (ACB)vs ›	$280.60M	N/A	46.08	46.08	46.08
Fate Therapeutics, Inc. (FATE)vs ›	$279.16M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.87

Forward EPS (Est.)

$-1.39

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

LRMR PE Ratio Metrics

LRMR Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics